A Single Dose Pharmacokinetic Study of LY2409021 in Healthy Subjects to Bridge Formulations From Capsules to Commercial Tablets
Phase of Trial: Phase I
Latest Information Update: 17 Jun 2015
At a glance
- Drugs Adomeglivant (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 10 Jun 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 14 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 19 Mar 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.